Blood Coagulation Disorders: all 147 studies

Page 1 of 2. Open to participants first (15), then studies with results posted, then the rest; newest registration first within each.

• External Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform AnalysisRecruitingNCT07418099
• Comparative Study of Tranexamic Acid Dosing in Cardiac SurgeryRecruitingNCT07164300Not applicable
• A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP)RecruitingNCT07059000Phase 3
• Early Genomic Testing for Inherited Bleeding DisordersRecruitingNCT06736158Early Phase 1
• Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive SurgeryRecruitingNCT06617897Phase 3
• Evaluation of Clinical Ranges of Whole Blood Clotting Times of Patients on AnticoagulantsNot yet recruitingNCT06582563
• Transfusion Surveillance in AnaesthesiaRecruitingNCT06403163
• Application of a New Type of Whole Blood Coagulation Time Measurement in Evaluating the Hypercoagulable State of Malignant TumorsRecruitingNCT05939960
• Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)RecruitingNCT05776069Phase 1/2
• A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)Enrolling by invitationNCT05768386
• Biomarkers and Prediction of Tigecycline Induced Coagulation DysfunctionNot yet recruitingNCT05698160
• Transmission Electron Microscopy Images for Platelet Ultrastructural Criteria Before and After the Onset of an Antiplatelet AgentRecruitingNCT05004233Not applicable
• Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD)RecruitingNCT03255928
• Investigation of the Genetics of Hematologic DiseasesRecruitingNCT02720679
• The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic TestingRecruitingNCT01280825
• An 18-month Low-interventional Study to Assess Joint Health in Haemophilia A and B Patients on Prophylaxis With Efmoroctocog Alfa or Eftrenonacog AlfaTerminatedNCT05856266Phase 4Results posted
• The Effectiveness of a Novel Software Program to Help in ROTEM InterpretationCompletedNCT05591014Not applicableResults posted
• Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec, With Prophylactic Steroids in Hemophilia ACompletedNCT04323098Phase 3Results posted
• Safety and Pharmacokinetics of Subcutaneous Injection of OCTA101 in Adult Patients With Severe Hemophilia ATerminatedNCT04046848Phase 1/2Results posted
• Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII InhibitorsCompletedNCT03734588Phase 1/2Results posted
• Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5TerminatedNCT03520712Phase 1/2Results posted
• A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without InhibitorsCompletedNCT03417245Phase 3Results posted
• A Study of Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients With InhibitorsCompletedNCT03417102Phase 3Results posted
• Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients at a Dose of 4E13 vg/kgCompletedNCT03392974Phase 3Results posted
• Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients (BMN 270-301)CompletedNCT03370913Phase 3Results posted
• A Gene Transfer Study for Hemophilia ACompletedNCT03003533Phase 1/2Results posted
• Does Plasma Reduce Bleeding in Patients Undergoing Invasive ProceduresCompletedNCT02637427Phase 3Results posted
• Gene Therapy Study in Severe Haemophilia A Patients (270-201)CompletedNCT02576795Phase 1/2Results posted
• A Gene Therapy Study for Hemophilia BCompletedNCT02484092Phase 2Results posted
• Short-term Cardiovascular Benefits of Wearing Particulate-filtering RespiratorsCompletedNCT02238028Not applicableResults posted
• A Prospective Study of Airless Tubing in an Inpatient Acute Hemodialysis Unit in Hospitalized PatientsCompletedNCT02086682Results posted
• A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MFCompletedNCT01787552Phase 1/2Results posted
• Exploratory Phase II Study of INC424 Patients With Primary Myelofibrosis (PMF) or Post Polycythaemia Myelofibrosis (PPV MF) or Post Essential Thrombocythaemia Myelofibrosis (PET-MF)CompletedNCT01558739Phase 4Results posted
• The Effect of the Hemobag® Ultrafiltration System on Blood Conservation and Coagulation After Cardiopulmonary BypassCompletedNCT01435304Not applicableResults posted
• Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia ATerminatedNCT01434511Phase 3Results posted
• Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia ACompletedNCT01178294Phase 2/3Results posted
• Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia ACompletedNCT01029340Phase 3Results posted
• Clinical and Economic Implications of Genetic Testing for Warfarin ManagementCompletedNCT00964353Phase 4Results posted
• A Comparison of Crotalinae Equine Immune F(ab)2 Antivenom (Anavip) and Crotalidae Polyvalent Immune Fab,CompletedNCT00868309Phase 2Results posted
• Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant TherapyCompletedNCT00708435Phase 3Results posted
• Effects of Lumbrokinase DLBS1033 on D-Dimer, Interleukin-6, and Clinical Outcomes in Patients With Pneumonia and SepsisCompletedNCT07892794Phase 2
• A Study Investigating Coagadex in the Treatment AFXD Associated With AL AmyloidosisWithdrawnNCT06963216Phase 3
• Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog AlfaActive, not recruitingNCT06940830Phase 4
• Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog AlfaActive, not recruitingNCT06716814Phase 3
• Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia ACompletedNCT06579144Phase 1
• The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)WithdrawnNCT06291415Phase 1
• Phase 3 Study for Efficacy and Safety Outcomes Data in Japanese Patients With Severe Hemophilia AActive, not recruitingNCT06224907Phase 3
• The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated HeparinCompletedNCT06174961Phase 4
• Effects of Platelet Mimicking Nanoparticles in Patients With CirrhosisCompletedNCT06050993
• Study of TU7710 in Warfarin Anti-coagulated Healthy Male SubjectsCompletedNCT06025552Phase 1
• A Study Evaluating Physical Activity and Joint Health in Severe Haemophilia A Patients ≥12 Years Treated Once Weekly With Efanesoctocog AlfaCompletedNCT05817812Phase 3
• Goal-directed vs. Empirical Tranexamic Acid Administrationin Cardiovascular SurgeryCompletedNCT05806346Not applicable
• A Study to Learn More About Treatment With Damoctocog Alfa Pegol, How it is Used in Every Day Practice ("Real-World"), and How Satisfied People Who Receive Damoctocog Alfa Pegol Are in United States (US) Hemophilia Treatment CentersTerminatedNCT05395858
• The Combination of Sitagliptin and Danazol as the Treatment of Steroid-resistant/Relapse Immune ThrombocytopeniaStatus unknownNCT05353673Phase 2
• Thromboelastographic Methods in Deciding Therapy on Moderate to Severe COVID-19 PatientsCompletedNCT05343728
• Mitochondrial Dysfunction in Trauma-related CoagulopathyStatus unknownNCT05004844
• Hypercoagulability Study Using Haemostatic Techniques in Patients With Inflammatory Bowel DiseaseStatus unknownNCT04896203
• Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 PatientsCompletedNCT04818970Not applicable
• Thrombin Generation in Liver Transplant SurgeryStatus unknownNCT04762550
• Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior InhibitorsCompletedNCT04684940Phase 1/2
• Coagulation and Vitamin K in Head and Neck Microvascular Free Flap SurgeryCompletedNCT04517461
• Palonosetron and Blood CoagulationStatus unknownNCT04507711Not applicable
• Ondansetron and Blood CoagulationStatus unknownNCT04499274Not applicable
• Analysis of the Coagulopathy Developed by COVID-19 Infected PatientsCompletedNCT04356950
• Thrombomodulin-modified Thrombin Generation Assay (TGA-TM) in Patients With Critical InfectionsCompletedNCT04356144
• AAV Gene Therapy Screening/Observational Protocol (ECLIPSE)CompletedNCT04272554
• Dexmedetomidine and Blood CoagulationCompletedNCT04269278
• Bleeding in Hospitalized Patients With Liver Disease Undergoing Invasive ProceduresCompletedNCT04076605
• Comparison of Two D-Dimers Dosing TechniquesCompletedNCT03972839
• An International Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia BCompletedNCT03901755
• Fibrinogen Concentrate In Children Cardiac Surgery 2Status unknownNCT03884725Phase 4
• Blood Cell Adhesion to Arterial Filters During Cardiac SurgeryStatus unknownNCT03882593
• Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A ParticipantsCompletedNCT03876301
• Sequential Compression Devices Effect on Fibrinolysis in Plastic Surgery OutpatientsCompletedNCT03821597Not applicable
• Viscoelastic Tests-Guided Therapy In Liver TransplantationCompletedNCT03756948Not applicable
• NOAC Plasma Concentration and Blood Coagulation in Healthy VolunteersCompletedNCT03666650Phase 4
• A Study to Evaluate the Real-world Effectiveness and Usage of Alprolix in Patients With Haemophilia B in FranceCompletedNCT03655340
• Blood Transfusion and Postoperative Outcome Before and After Implementing a Coagulation Management AlgorithmCompletedNCT03482128
• Effects of Prophylactic Desmopressin on Blood Coagulation Parameters in Heart Valve SurgeryStatus unknownNCT03343418Phase 4
• Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial FibrillationCompletedNCT03280368
• Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and BCompletedNCT03276130
• Noninvasive Measurement of Blood CoagulationStatus unknownNCT03217799
• Assessment of Blood Coagulation Disorders in Patients With Pulmonary HypertensionStatus unknownNCT03195543
• Plasmalyte-148 Solution and Blood CoagulationCompletedNCT03168087
• Characteristics of Primary and Plasmatic Hemostasis in PreeclampsiaStatus unknownNCT03149250
• Irrigating Fluid and Blood CoagulationCompletedNCT03105180
• A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or BCompletedNCT03055611
• Vascular Cell Activation, Cell-Derived Microparticles and In Vitro Fertilisation, and In Vitro FertilisationCompletedNCT03051230
• Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor ProductsCompletedNCT02976753
• Cost-Utility Analysis of Management of Peri Operative Haemorrhage Following Cardiac Surgery With Cardiopulmonary BypassCompletedNCT02972684Not applicable
• Dental Extractions in Patients Under Dual Antiplatelet TherapyCompletedNCT02918045Not applicable
• Determination of Fibrin Activity in Plasma on STA-R® PrototypeCompletedNCT02856789
• Major Liver Resection: Early Clotting Disorders and Functional Impairment.CompletedNCT02813538
• The Effect of Voltaren-ophtha 0.1% Eye Drops on INR Levels (International Normalized Ratio) in Patients Taking WarfarinStatus unknownNCT02782338
• Patient-Centered Anticoagulation Self-Monitoring in Minority PatientsCompletedNCT02776566Not applicable
• Pilot Study to Compare Fresh Frozen Plasma With 24-Hour Plasma in Babies Up to Age Six MonthsWithdrawnNCT02774317Phase 4
• The Fear F8ctor Study - Does Fear Induce a Blood Curdling State?CompletedNCT02601053Not applicable
• Transfusion of Plasma Prior to Invasive Procedures Pilot Trial (TOPPIT)Status unknownNCT02561026Phase 3
• Bedside Evaluation of Coagulation in Children With Congenital Heart DiseaseCompletedNCT02387944
• ROTEM® Sigma Performance Evaluation - Method Comparison With Predicate Device and Reference IntervalsStatus unknownNCT02379104

← Blood Coagulation Disorders overview